Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,578,662
-
Share change
-
+6,476,906
-
Total reported value
-
$128,584,918
-
Put/Call ratio
-
0%
-
Price per share
-
$3.62
-
Number of holders
-
96
-
Value change
-
+$23,475,156
-
Number of buys
-
46
-
Number of sells
-
48
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q4 2019
As of 31 Dec 2019,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,578,662 shares.
The largest 10 holders included
BVF INC/IL, Aquilo Capital Management, LLC, BlackRock Inc., EcoR1 Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Candriam Luxembourg S.C.A., Tekla Capital Management LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, and STATE STREET CORP.
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.